Deli e able D1.1
Web access pla o m
This p ojec has ecei ed unding om he Eu opean Union’s Ho izon 2020 esea ch and
inno a ion p og amme unde g an ag eemen No 101008571 (PRISMAP). This
documen e lec s only he iew o he au ho (s). The Agency is no esponsible o any
use ha may be made o he in o ma ion i con ains.
Deli e able D1.1
ii
P ojec Ac onym
PRISMAP
P ojec Ti le
The Eu opean medical iso ope p og amme: P oduc ion o high pu i y
iso opes by mass sepa a ion
G an Ag eemen No.
101008571
Topic
INFRAIA-02-2020: In eg a ing Ac i i ies o S a ing Communi ies
P ojec s a da e
01 May 2021
Na u e
Repo
Dissemina ion le el
Public
Due da e
M03
Da e o deli e y
M03
Lead pa ne
SCIPROM
Con ibu ing pa ne s
ARRONAX, CERN
Au ho s
Fe id Haddad, Anne Le Penned, Celine He aul (ARRONAX), Ki s en Leu gen,
I is Dimbwadyo (SCIPROM)
Re iewe
Thie y S o a, Cha lo e Duchemin (CERN), Maija Radzina (LU)
Poin o Con ac
Fe id Haddad
Ins i u ion
ARRONAX
E-mail
haddad@suba ech.in2p3.
Phone
+33-2-28-21-21-21
© PRISMAP 2021. This wo k is licensed unde a C ea i e Commons
A ibu ion-NonComme cial-NoDe i a i es 4.0 In e na ional License.
Deli e able D1.1
iii
Re ision His o y
Ve sion
Da e
Au ho
Commen
0.1
16.07.2021
Fe id Haddad
Fi s d a
0.2
20.07.2021
Ki s en Leu gen, I is Dimbwadyo
Re iew, sugges ions, ques ions
21.07.2021
Execu i e Boa d
Discussion
0.5
22.07.2021
Ki s en Leu gen, I is Dimbwadyo
Concep ualisa ion, e ision and comple ion
based on EB discussion
0.6
26.07.2021
Pe e Ul ich
In e nal e iew and e isions
0.7
26.07.2021
Ki s en Leu gen
Re iew and e isions. Ve sion o conso ium
in e nal e iew
0.8
27.07.2021
Cha lo e Duchemin, Maija
Radzina, I is Dimbwadyo
Compiled eedback om he conso ium
e iewe s
0.85
29.07.2021
Ki s en Leu gen, Pe e Ul ich, I is
Dimbwadyo
Re iew and e isions
0.9
29.07.2021
Thie y S o a
Re iew by he coo dina o
1.0
30.07.2021
Pe e Ul ich
Final e sion, app o ed by he coo dina o
Deli e able D1.1
i
Con en s
Abb e ia ions, Pa icipan sho names
...
Abb e ia ions
…
Pa icipan sho names
Summa y 1
... 1
// Keep his line in place. I is need o ix a W o d-bug in he TOC. 1
1. In oduc ion 2
… 2
... 2
2. Websi e s uc u e 2
… 2
3. Access pla o m 3
3.1 In oduc o y ex 3
3.2 PRISMAP guide o applican s 3
3.2.1 Eligibili y, ules and condi ions 3
3.2.2 Dissemina ion and epo ing 4
3.2.3 Co e age 4
3.2.4 T anspo a ion 5
3.2.5 E hics 5
3.2.6 PRISMAP use p ojec ag eemen 5
3.2.7 Applica ion o m 5
4. Conclusions 6
Deli e able D1.1
Abb e ia ions, Pa icipan sho names
...
Abb e ia ions
…
GA
G an Ag eemen
H2020
The Eu opean Union’s Ho izon 2020 esea ch and inno a ion p og amme
(Radio)iso ope/
nuclide
(Radio)iso opes a e ( adio)nuclides o he same elemen 1
TNA
T ansna ional access ac i i y
UF
Use Fo um
UG
Use G oup
USP
Use Selec ion Panel
Pa icipan sho names
CERN
Eu opean o ganiza ion o nuclea esea ch
NPL
Na ional Physical Labo a o y
PSI
Paul Sche e Ins i u
CEA
Commissa ia à l’éne gie a omique e aux éne gies al e na i es
IST-ID
Associação do Ins i u o Supe io Técnico pa a a IST-ID In es igação e
Desen ol imen o
DTU
Danma ks Tekniske Uni e si e
CHUV
Cen e hospi alie uni e si ai e audois
GANIL
G and Accélé a eu Na ional d’Ions Lou ds
SCK CEN
S udiecen um oo Ke nene gie / Cen e d'é ude de l'éne gie nucléai e
ARRONAX
G oupemen d’in é ê public ARRONAX
ESS
Eu opean spalla ion sou ce ERIC
TUM
Klinikum ech s de Isa de echnischen Uni e si ä München
KULeu en
Ka holieke Uni e si ei Leu en
MedAus on
En wicklungs- und Be iebsgesellscha MedAus on GmbH
SCIPROM
SCIPROM Sà l
MUI
Medizinische Uni e si ä Innsb uck
ILL
Ins i u Max on Laue - Paul Lange in
JRC
JRC -Join Resea ch Cen e- Eu opean Commission
1
Consensus nomencla u e ules o adiopha maceu ical chemis y, h ps://doi.o g/10.1016/j.nucmedbio.2017.09.004. 47Ca and i s
daugh e 47Sc a e bo h adionuclides, bu when named in he same ph ase one would o mally no use he e m " adioiso opes"
because hey belong o wo di e en chemical elemen s. Howe e , his o ically he e m “iso ope” o “ adioiso ope” was o en used
synonymously wi h “ adionuclide” and medical li e a u e pa ially e lec s his p ac ice. Thus, also he p esen ex may
occasionally depa om he p esc ibed con en ions o imp o ed eadabili y.
Deli e able D1.1
i
NCBJ
Na odowe Cen um Badań Jąd owych
GSI
GSI Helmhol zzen um Schwe ionen o schung GmbH
LU
La ijas Uni e si ā e
INFN
Is i u o Nazionale di Fisica Nuclea e
UiO
Uni e si e e i Oslo
Summa y
...
// Keep his line in place. I is need o ix a Wo d-bug in he TOC.
PRISMAP - The Eu opean medical iso ope p og amme will p o ide access o inno a i e medical adionuclides
and hei applica ions by a conso ium o key Eu opean in as uc u es, wi h ha monised p ocedu es h ough
a single web-based access pla o m.
This deli e able D1.1 desc ibes he PRISMAP applica ion p ocedu es o g an access o he PRISMAP se ices
p o ided o he p epa a ion o adionuclides and hei medical applica ion.
This documen desc ibes how he access pla o m will be in eg a ed in o he PRISMAP websi e and includes
a summa y ex o he dedica ed webpage, a desc ip ion o he guide o applican s, which will be made
a ailable o download on his page, as well as o he online use applica ion o m.
The guide o applican s includes an in oduc ion o he applica ion p ocedu es and equi emen s, he
selec ion c i e ia and guidance o he use applica ion o m.
The use applica ion o m consis s o wo pa s: Pa A is comple ed h ough online o ms and p o ides mainly
adminis a i e in o ma ion. Pa B includes a desc ip ion o he p oposed scien i ic p ojec , o be uploaded
as a pd ile.
The con en s and o ma o he applica ion p ocedu es incl. he use applica ion o m may e ol e o e ime
acco ding o he eedback om conso ium membe s, he PRISMAP Use Selec ion Panel (USP) and he
PRISMAP Use Fo um (UF) ep esen ing ou p esen and u u e use s.
To complemen he p esen D1.1, he adionuclide p oduc ion and medical applica ion se ice po olios a e
de ailed in deli e ables D2.1 and D3.1, espec i ely. The i s e sion o he PRISMAP websi e is desc ibed in
deli e able D7.1. All ou deli e ables a e due a e p ojec mon h 3 and will be cumula ed in a mo e
comple e websi e soon a e hei submission.
Deli e able D1.1
2
1. In oduc ion
…
...
This deli e able D1.1 desc ibes he PRISMAP applica ion p ocedu es o g an access o he PRISMAP se ices
o he p epa a ion o adionuclides and hei medical applica ion. This documen includes a summa y ex
o he dedica ed page o he PRISMAP websi e, a desc ip ion o he guide o applican s which will be made
a ailable o download on his page as well as he online Use Applica ion Fo m. We also desc ibe how he
in o ma ion o his deli e able will be embedded in he PRISMAP websi e (D7.1), oge he wi h he
in o ma ion abou ou se ice po olios as desc ibed in D2.1 and D3.1.
2. Websi e s uc u e
…
The PRISMAP p ojec aiming a building a Eu opean ne wo k o medical iso opes will use i s websi e (D7.1)
o desc ibe he access p ocedu es and equi emen s and collec use p oposals applying o he p oduc ion
o adionuclides and/o o hei medical applica ion wi hin one o he PRISMAP acili ies.
As illus a ed in Figu e 1, his websi e is di ided in o wo pa s: A i s pa dedica ed o PRISMAP as a H2020
unded p ojec , desc ibing he p ojec , i s conso ium, p og ess and achie emen s; as well as a second pa
dedica ed o he se ices which PRISMAP p o ides o he p oduc ion and use o medical adionuclides. Bo h
pa s can be eached ia he same domain name. Di e en colou schemes a e used o hese di e en pa s.
I is en isaged ha he Medical Radionuclides pa will be used and u he de eloped beyond he ame o
he PRISMAP p ojec . Al eady now his pa o he PRISMAP websi e can also be eached ia he domain
www.medical- adionuclides.eu, which edi ec s o h ps://www.p ismap.eu/ adionuclides/.
The Medical Radionuclides pa o he websi e will consis o wo sec ions:
1. An access pla o m h ough which ex e nal use s will be able o apply o access o PRISMAP
in as uc u es and se ices. This pla o m will ini ially include an in oduc o y ex , a downloadable
guide o applican s and an online applica ion o m. The cu en deli e able, D1.1, will p o ide his
sec ion wi h he in o ma ion and s uc u e necessa y o use s o apply o hese se ices. This will be
comple ed o e ime e.g. by summa ies o all use p ojec s and esul ing publica ions.
2. A map o iso opes and se ices o e ed wi hin he PRISMAP p ojec , ele an in o ma ion on medical
applica ions and aining. Ini ial in o ma ion o his sec ion will be p o ided by D2.1 and D3.1, also due
a e p ojec mon h M03.
Figu e 1. PRISMAP websi e s uc u e
Deli e able D1.1
3
3. Access pla o m
The access pla o m will ini ially include an in oduc o y ex , a downloadable guide o applican s and an
online use applica ion o m.
3.1 In oduc o y ex
The ollowing in oduc o y ex o he PRISMAP access pla o m is sugges ed:
PRISMAP ede a es a conso ium o he key Eu opean in ense neu on sou ces, iso ope mass sepa a ion
acili ies and high-powe accele a o s and cyclo ons, wi h leading biomedical esea ch ins i u es and
hospi als ac i e in he ansla ion o he new adionuclides in o medical diagnosis and ea men , in suppo
o he medical adionuclide use communi y.
I will c ea e a single-en y poin o a s a ing use communi y dis ibu ed amongs uni e si ies, esea ch
cen es, indus y and hospi als, and u he ecei es suppo o leading associa ions and ins i u ions in he
ield such as he Eu opean Associa ion o Nuclea Medicine (EANM) and he In e na ional A omic Ene gy
Agency (IAEA).
Ou main goal is o p o ide a sus ainable sou ce o high pu i y g ade new adionuclides o medicine, access
o medical esea ch labo a o ies able o handle hese adionuclides; and hus, enable and accele a e ea ly
phase esea ch on adiopha maceu icals, a ge ed d ugs o cance , he anos ics and pe sonalised medicine,
shaping he Eu opean adionuclide landma k as a gold s anda d.
We a e pleased o o e he ollowing ansna ional access p og amme and co e ela ed cos s om he
PRISMAP budge :
P ojec s selec ed based on excellence by an in e na ional expe panel, he PRISMAP Use Selec ion Panel
P oduc ion and deli e y o adionuclides o he app o ed medical esea ch p ojec s, excluding shipping
cos s
Access o a selec ion o medical esea ch labo a o ies, o selec ion o p eclinical esea ch echniques ully
pe o med as a se ice o he app o ed medical esea ch p ojec s
T a el, subsis ence and local accommoda ion cos s a e NOT co e ed unde PRISMAP.
Fo mo e de ails abou ules and condi ions as well as ins uc ions o he Use Applica ion Fo m please e e
o he PRISMAP guide o applican s. Fo he submission o you use applica ion, please mo e o he
Submission Po al.
3.2 PRISMAP guide o applican s
The PRISMAP guide o applican s is in ended o explain o use s how o apply o PRISMAP se ices. I also
de ines he c i e ia ha use s mus mee o success ully apply o he use o hese se ices.
The documen includes an in oduc ion o he applica ion p ocedu es and equi emen s, he selec ion
c i e ia and ins uc ions o he use applica ion o m.
3.2.1 Eligibili y, ules and condi ions
The ollowing is a summa y o he ules, condi ions and eligibili y go e ning ansna ional access o he
in as uc u es pa icipa ing in PRISMAP. These ules a e o mula ed by he PRISMAP Conso ium based on
he ele an p o isions o he Eu opean Commission’s G an Ag eemen (GA). In case o any con lic , he
p o isions o he GA ake p ecedence.
The P incipal Scien is and he majo i y o he use s mus wo k in a coun y o he han he coun y(ies)
whe e he in as uc u e is loca ed ( his ule applies o he en i e du a ion o he access pe iod). A Use
G oup (UG) conduc ing hei esea ch in he coun y o he in as uc u e is no eligible. I se e al
